Genetic risk factors for variant Creutzfeldt–Jakob disease: a genome-wide association study

[1]  J. Collinge,et al.  Successful amplification of degraded DNA for use with high‐throughput SNP genotyping platforms , 2008, Human mutation.

[2]  G. Hutter,et al.  Transcriptional stability of cultured cells upon prion infection. , 2008, Journal of molecular biology.

[3]  J. Stockman.  Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt Jakob disease associated with blood transfusion: a case report , 2008 .

[4]  D. Stephan,et al.  A survey of genetic human cortical gene expression , 2007, Nature Genetics.

[5]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[6]  Suvankar Pal,et al.  Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report , 2006, The Lancet.

[7]  T. Illig,et al.  Significant association of a M129V independent polymorphism in the 5′ UTR of the PRNP gene with sporadic Creutzfeldt-Jakob disease in a large German case-control study , 2006, Journal of Medical Genetics.

[8]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[9]  John Collinge,et al.  Kuru in the 21st century—an acquired human prion disease with very long incubation periods , 2006, The Lancet.

[10]  Dawn Everington,et al.  Risk factors for variant Creutzfeldt–Jakob disease: A case–control study , 2006, Annals of neurology.

[11]  Mrc Prion.  Kuru in the 21st century-an acquired human prion disease with very long incubation periods , 2006 .

[12]  J. Collinge,et al.  Disease-related Prion Protein Forms Aggresomes in Neuronal Cells Leading to Caspase Activation and Apoptosis* , 2005, Journal of Biological Chemistry.

[13]  J Collinge,et al.  Molecular neurology of prion disease , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[14]  Johannes Beckers,et al.  Cell line dependent RNA expression profiles of prion-infected mouse neuronal cells. , 2005, Journal of molecular biology.

[15]  J. Langeveld,et al.  Manipulation of PrPres production in scrapie-infected neuroblastoma cells , 2004, Journal of Neuroscience Methods.

[16]  Mark Penney,et al.  Prevalence of lymphoreticular prion protein accumulation in UK tissue samples , 2004, The Journal of pathology.

[17]  J. Ironside,et al.  Variant Creutzfeldt-Jakob disease. , 2004, Folia neuropathologica.

[18]  L. Stoltze,et al.  A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Michael P H Stumpf,et al.  Balancing Selection at the Prion Protein Gene Consistent with Prehistoric Kurulike Epidemics , 2003, Science.

[20]  J. Collinge,et al.  Identification of genetic loci affecting mouse-adapted bovine spongiform encephalopathy incubation time in mice , 2002, Neurogenetics.

[21]  M. Lanotte,et al.  All-trans retinoic acid down-regulates prion protein expression independently of granulocyte maturation , 2002, Leukemia.

[22]  K. Lee,et al.  Regulation of the Cellular Prion Protein Gene Expression Depends on Chromatin Conformation* , 2002, The Journal of Biological Chemistry.

[23]  M. Farrall,et al.  Sporadic--but not variant--Creutzfeldt-Jakob disease is associated with polymorphisms upstream of PRNP exon 1. , 2001, American journal of human genetics.

[24]  E. Fisher,et al.  Identification of multiple quantitative trait loci linked to prion disease incubation period in mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Alpers,et al.  Increased susceptibility to Kuru of carriers of the PRNP 129 methionine/methionine genotype. , 2001, The Journal of infectious diseases.

[26]  J. Collinge.  Prion diseases of humans and animals: their causes and molecular basis. , 2001, Annual review of neuroscience.

[27]  S. Prusiner,et al.  Quantitative trait loci affecting prion incubation time in mice. , 2000, Genomics.

[28]  B. Steinhoff,et al.  How to improve the clinical diagnosis of Creutzfeldt-Jakob disease. , 1999, Brain : a journal of neurology.

[29]  S. Cousens,et al.  Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent , 1997, Nature.

[30]  Andrew F. Hill,et al.  The same prion strain causes vCJD and BSE , 1997, Nature.

[31]  Andrew F. Hill,et al.  Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD , 1996, Nature.

[32]  John Collinge,et al.  Homozygous prion protein genotype predisposes to sporadic Creutzfeldt–Jakob disease , 1991, Nature.

[33]  T. Crow,et al.  Codon 129 changes in the prion protein gene in Caucasians. , 1990, American journal of human genetics.

[34]  V. Zigas,et al.  KURU: CLINICAL STUDY OF A NEW SYNDROME RESEMBLING PARALYSIS AGITANS IN NATIVES OF THE EASTERN HIGHLANDS OF AUSTRALIAN NEW GUINEA , 1957, The Medical journal of Australia.

[35]  C. Watson.  A case of mesenteric vascular occlusion. , 1949, The Medical journal of Australia.